A new study finds that is particularly true for people nearing retirement.

a new generic formulation of bupropion hydrochloride. This marks the company's eighth antidepressant released to the market. Bupropion is a norepinephrine dopamine reuptake inhibitor (NDRI); it is ...

Since the 1980s, selective serotonin reuptake inhibitor (SSRI) antidepressants have been the ... SSRIs and proposing the use of these drugs in new clinical applications. In this work, all ...

Moreover, rise in geriatric population and, increase in number of approvals for the development of antidepressant drugs is creating new opportunities to the market. However, side effects associated ...

Researchers from Muncie, Ind.-based Ball State University examined data from approximately 300 metropolitan areas, tracking local stock prices and antidepressant prescriptions over the course of two ...

There has been a new antidepressant on the market every two or three years. In 1987, the antidepressant fluoxetine (Prozac) was introduced. It had been tested by the FDA and found to be an ...

Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD) hasn't made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate ...

In addition, studies in the early 2000s found that the newer antidepressants were associated with a heightened risk of suicidal thoughts and attempts among children, adolescents, and young adults.

Researchers have used a drug screening platform they developed to show that an antidepressant, currently on the market ... a view to use existing drugs for new purposes. For the screening ...

The purpose of this study was to find ways to facilitate formulary decisions by an MCO regarding selection of antidepressants for the treatment of major depressive disorders. To accomplish this ...

Sexual side effects have emerged as a major clinical concern with many of the newer antidepressants. Approximately 30% to 40% of patients on serotonergic antidepressants experience sexual dysfunction.